コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 o Rheumatoid Dysplasia (PPRD) a debilitating musculoskeletal disorder.
2 enerative properties results in debilitating musculoskeletal disorders.
3 ed relates to an increased susceptibility to musculoskeletal disorders.
4 d pectus excavatum (PE) are common pediatric musculoskeletal disorders.
5 P2X7 in inflammatory, immune, neurologic, or musculoskeletal disorders.
6 to translational studies in gene therapy of musculoskeletal disorders.
7 st important and challenging consequences of musculoskeletal disorders.
8 ces of some of the more common, work-related musculoskeletal disorders.
9 duct large-scale studies of neurological and musculoskeletal disorders.
10 ffectively combat congenital and age-related musculoskeletal disorders.
11 model of PCS focused on neuropsychiatric and musculoskeletal disorders.
12 t tissues simultaneously in rodent models of musculoskeletal disorders.
13 e puerperium, but negatively associated with musculoskeletal disorders.
14 risk during surgery may reduce work-related musculoskeletal disorders.
15 gical ergonomics and preventing work-related musculoskeletal disorders.
16 atory, cellular, and gene therapies to treat musculoskeletal disorders.
17 .80 (95% CI 0.80-0.81) for participants with musculoskeletal disorders, 0.83 (0.82-0.84) for those wi
18 area that contributed most to prevalence was musculoskeletal disorders (1.71 billion people [1.68-1.8
19 diagnoses); inborn errors of metabolism and musculoskeletal disorders (11% each); lymphatic, neurode
20 placebo-treated patients, respectively) and musculoskeletal disorders (14.6% and 21.4%, respectively
21 rs, female surgeons were more likely to have musculoskeletal disorders (255 of 692 [36.9%] vs 29 of 1
22 f patients in arm A vs 19 [7%] in arm D) and musculoskeletal disorders (30 [6%] of patients in arm A
26 e of the spine, is the most common pediatric musculoskeletal disorder, affecting ~3% of the populatio
27 ven the overrepresentation of depression and musculoskeletal disorders among women, increased emphasi
29 ssue (tendinopathy) is a frequent and costly musculoskeletal disorder and represents a major clinical
33 rs' work environment to prevent or alleviate musculoskeletal disorders and their personal and socioec
36 gh spending on low back and neck pain, other musculoskeletal disorders, and diabetes accounted for th
37 urden from mental and behavioural disorders, musculoskeletal disorders, and diabetes will impose new
38 requent with bosutinib, whereas neutropenia, musculoskeletal disorders, and edema were more frequent
39 ularly from mental disorders, substance use, musculoskeletal disorders, and falls deserves an integra
40 c conditions, vision and other sensory loss, musculoskeletal disorders, and genitourinary diseases).
41 resents a promising therapeutic strategy for musculoskeletal disorders, and interest has focused on m
42 ctors for work-related disability because of musculoskeletal disorders, and it discusses phases of ph
43 death at this time, as well as of diabetes, musculoskeletal disorders, and other categories of disea
46 levated job stress, and previously diagnosed musculoskeletal disorders are factors associated with in
48 al to revolutionize treatment approaches for musculoskeletal disorders, bringing renewed hope to the
49 the diagnostic utility of WGS for pediatric musculoskeletal disorders by comparing it with whole exo
50 g Rohingya refugees, particularly those with musculoskeletal disorders, cancer, and multimorbid condi
51 Myofascial pain syndrome (MPS), a chronic musculoskeletal disorder characterized by myofascial tri
52 injuries, mental disorders, premature birth, musculoskeletal disorders, congenital birth defects, ski
53 standardization of ultrasound assessment of musculoskeletal disorders continue to hamper its progres
55 udy including people with chronic disorders: musculoskeletal disorder, depression, migraine, respirat
56 urther clarify the genetic basis of specific musculoskeletal disorders, enhancing risk factor identif
57 onflation of all chronic pain syndromes with musculoskeletal disorders; exclusion of personality diso
58 order and behavioural problems, movement and musculoskeletal disorders, gastrointestinal and sleep pr
62 x 10(-8)) and a significant association with musculoskeletal disorders in the UK Biobank (p = 4.88 x
64 al disorders such as depression and anxiety, musculoskeletal disorders including low back pain and ne
66 e adiponectin in autoimmune diseases causing musculoskeletal disorders, including rheumatoid arthriti
67 t-soluble vitamin is usually associated with musculoskeletal disorder, it is associated with a wide r
68 ng method for improving our understanding of musculoskeletal disorders marked by genetic and phenotyp
71 lished to explore the hypothesis that common musculoskeletal disorders (MSDs) and associated disabili
73 e prevention of work-related upper extremity musculoskeletal disorders (MSDs; e.g., neck pain and sho
74 back pain, major depressive disorder, other musculoskeletal disorders, neck pain, and anxiety disord
75 h and may pose a risk for the development of musculoskeletal disorders of the distal upper extremity.
76 WES analysis for 36 pediatric patients with musculoskeletal disorders of unknown etiology and, where
77 ied medicine approaches for the treatment of musculoskeletal disorders offer opportunities to effecti
79 d into acute injuries (odds ratio = 1.2) and musculoskeletal disorder-related injuries (odds ratio =
80 analysis was repeated for acute injuries and musculoskeletal disorder-related injuries separately.
81 movement disorders, mental health disorders, musculoskeletal disorders, sensory disorders, Guillain-B
82 ic disorders (SR, 1.26 [95% CI, 1.06-1.47]), musculoskeletal disorders (SR, 1.18 [95% CI, 1.07-1.30])
83 The association between obesity and various musculoskeletal disorders such as slipped capital femora
84 nt of glucose metabolism, and dyslipidaemia; musculoskeletal disorders, such as myopathy, osteoporosi
86 illes tendinosis is a localized degenerative musculoskeletal disorder that develops over a long perio
88 ysical exposures in epidemiologic studies of musculoskeletal disorders when measures of individual ex
89 ny other health condition, followed by other musculoskeletal disorders, which includes joint pain and
90 investigators to identify the patients with musculoskeletal disorders who are most likely to benefit
91 tified medicine approaches across a range of musculoskeletal disorders, with a focus on genetic risk
92 for diagnosing and longitudinally monitoring musculoskeletal disorders, with ongoing hardware and sof
93 e known to cause a wide range of cardiac and musculoskeletal disorders, with skeletal myopathy mostly
96 d determining the risk level of Work-Related Musculoskeletal Disorders (WMSDs), a risk assessment fra